Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Epimmune issued U.S. patent for cancer therapeutic

Oct. 7, 1997

Merck & Co. focuses on farnesyltransferase inhibitors

Oct. 7, 1997

Kyowa Hakko's cytostatic agents progress in U.S. clinical trials

Oct. 6, 1997

Clinical pharmacokinetic study of panomifene described

Oct. 6, 1997

Gd-Tex in phase Ib: safety profile and maximum tolerated dose

Oct. 6, 1997

Femara launched in U.S.

Oct. 3, 1997

Sugen's angiogenesis inhibitor SU-5416 enters phase I

Oct. 3, 1997

Favorable phase II/III data for Targretin in CTCL reported at dermatology congress

Oct. 2, 1997

Safety profile of VRCTC-310 established in rabbits

Oct. 2, 1997

Camptosar available in Canada

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...